» Articles » PMID: 31312255

Is an Analysis of Copy Number Variants Necessary for Various Types of Kidney Ultrasound Anomalies in Fetuses?

Overview
Journal Mol Cytogenet
Publisher Biomed Central
Specialty Biochemistry
Date 2019 Jul 18
PMID 31312255
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to estimate the associations of copy number variants (CNVs) with fetal kidney ultrasound anomalies. A total of 331 fetuses with kidney ultrasound anomalies who underwent prenatal chromosomal microarray analyses were enrolled. The fetuses were classified into groups with isolated and nonisolated anomalies or according to the types of kidney anomalies.

Results: Clinically significant CNVs were identified in 3.4% or 7.3% of fetuses with isolated or nonisolated kidney anomalies, respectively. CNVs were more frequently identified in fetuses with abnormal embryonic migration of the kidneys (6.6%) than in fetuses with malformations of the renal parenchyma (4.7%) or anomalies of the urinary collecting system (3.4%). In particular, CNVs were most frequently detected in fetuses with ectopic kidneys (9.5%) but not in fetuses with horseshoe kidneys or isolated duplex kidneys. Among these CNVs, the most common were del(17)(q12q12) (1.2%) and del(22)(q11q11) (0.6%). The dup(17)(p12p12) and del(15)(q11.2q11.2) CNVs were identified in this study but not in previous studies. The del(X)(p11.4p11.4) and del(16)(p13.3p13.3) CNVs were further implicated as associated with kidney anomalies.

Conclusions: Fetuses with abnormal embryonic migration of the kidneys (particularly ectopic kidneys) showed a higher frequency of clinically significant CNVs, whereas fetuses with horseshoe kidneys or duplex kidneys were less frequently associated with these CNVs.

Citing Articles

Prenatal diagnosis and family analysis of 17q12 microdeletion syndrome with fetal renal abnormalities.

Zhang F, Gu Q, Song J, Zhao Y, Wang Z, Men S Front Genet. 2024; 15:1401315.

PMID: 38957807 PMC: 11217314. DOI: 10.3389/fgene.2024.1401315.


Identification of complex and cryptic chromosomal rearrangements by optical genome mapping.

Shi S, Huang P, Yan R, Li R Mol Cytogenet. 2023; 16(1):5.

PMID: 37101225 PMC: 10134526. DOI: 10.1186/s13039-023-00636-2.


Treatment for complete bilateral duplex kidneys with severe hydronephrosis and ureterectasis of the upper moiety in a child: A case report and literature review.

Wu C, Ji F, Zhang H, Yao Z, Li L, Yan B Front Surg. 2022; 9:1019161.

PMID: 36406369 PMC: 9666680. DOI: 10.3389/fsurg.2022.1019161.


Review of genetic testing in kidney disease patients: Diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups.

Claus L, Snoek R, Knoers N, van Eerde A Am J Med Genet C Semin Med Genet. 2022; 190(3):358-376.

PMID: 36161467 PMC: 9828643. DOI: 10.1002/ajmg.c.31995.


State of the Science for Kidney Disorders in Phelan-McDermid Syndrome: UPK3A, FBLN1, WNT7B, and CELSR1 as Candidate Genes.

McCoy M, Sarasua S, DeLuca J, Davis S, Phelan K, Rogers R Genes (Basel). 2022; 13(6).

PMID: 35741804 PMC: 9223119. DOI: 10.3390/genes13061042.


References
1.
Bartsch O, Wagner A, Hinkel G, Krebs P, Stumm M, Schmalenberger B . FISH studies in 45 patients with Rubinstein-Taybi syndrome: deletions associated with polysplenia, hypoplastic left heart and death in infancy. Eur J Hum Genet. 1999; 7(7):748-56. DOI: 10.1038/sj.ejhg.5200378. View

2.
Tatton-Brown K, Douglas J, Coleman K, Baujat G, Cole T, Das S . Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet. 2005; 77(2):193-204. PMC: 1224542. DOI: 10.1086/432082. View

3.
Hennekam R . Rubinstein-Taybi syndrome. Eur J Hum Genet. 2006; 14(9):981-5. DOI: 10.1038/sj.ejhg.5201594. View

4.
Gervasini C, Castronovo P, Bentivegna A, Mottadelli F, Faravelli F, Giovannucci-Uzielli M . High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints. Genomics. 2007; 90(5):567-73. DOI: 10.1016/j.ygeno.2007.07.012. View

5.
Roelfsema J, Peters D . Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev Mol Med. 2007; 9(23):1-16. DOI: 10.1017/S1462399407000415. View